- Home
- HERE vs AARD Comparison
HERE vs AARD Comparison
Compare HERE & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HERE | AARD |
|---|---|---|
| Founded | 2019 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.6M | 97.4M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HERE | AARD |
|---|---|---|
| Price | $1.53 | $3.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $4.60 | ★ $11.11 |
| AVG Volume (30 Days) | 14.3K | ★ 98.3K |
| Earning Date | 12-01-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.11 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $182.30 | N/A |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $3.35 |
| 52 Week High | $5.80 | $16.60 |
Technical Indicators
Market Signals| Indicator | HERE | AARD |
|---|---|---|
| Relative Strength Index (RSI) | 28.74 | 29.53 |
| Support Level | $1.50 | $3.38 |
| Resistance Level | $1.94 | $5.88 |
| Average True Range (ATR) | 0.05 | 0.46 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 20.45 | 9.41 |
Price Performance
Historical ComparisonAbout HERE Here Group Limited American Depositary Shares
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.